{"title":"Body","authors":"Jarryd Terblanche","doi":"10.2307/j.ctv1b74285.80","DOIUrl":null,"url":null,"abstract":"• Severe renal impairment (eGFR less than 30 mL/min/1.73 m2), end These highlights do not include all the information needed to use stage renal disease, or patients on dialysis. (4, 5.1, 5.2) SEGLUROMET safely and effectively. See full prescribing • Metabolic acidosis, including diabetic ketoacidosis. (4, 5.1) information for SEGLUROMET. • Hypersensitivity to ertugliflozin, metformin or any excipient. (4)","PeriodicalId":387735,"journal":{"name":"Best New African Poets 2019 Anthology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Best New African Poets 2019 Anthology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2307/j.ctv1b74285.80","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
• Severe renal impairment (eGFR less than 30 mL/min/1.73 m2), end These highlights do not include all the information needed to use stage renal disease, or patients on dialysis. (4, 5.1, 5.2) SEGLUROMET safely and effectively. See full prescribing • Metabolic acidosis, including diabetic ketoacidosis. (4, 5.1) information for SEGLUROMET. • Hypersensitivity to ertugliflozin, metformin or any excipient. (4)
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
